A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP) (NCT06944925)
A Randomized, Double-Blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Patients With COPD or CRSwNP
🩺 Plain-English Summary (8th-Grade Level)
Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Who can join: Review the eligibility criteria below.
Location: Equity Medical Bowling Green — Bowling Green, Kentucky
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- Equity Medical Bowling Green — Bowling Green, Kentucky
- Equity Medical - Owensboro — Owensboro, Kentucky
- Equity Medical LLC — New York, New York
- Linear Clinical Research — Perth, Western Australia
- Momentum Clinical Research — Brisbane,
- Aleksandre Aladashvili Clinic LLC — Tbilisi,
- Geo Hospitals Tbilisi Multiprofile Medical Center — Tbilisi,
- LEPL The First University Clinic of Tbilisi State Medical University — Tbilisi,
- Ltd Aversi Clinic — Tbilisi,
- Momentum Clinical Research Hamilton — Rotorua, Hamilton
- Momentum Clinical Research — Pukekohe,
- Momentum Clinical Research — Wellington,
- Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz — Gdansk,
- Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o. — Krakow,
📞 Contact the Study Coordinator
Phone: +86 18001322760
Email: Tracy.Ji@bambusatx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Obstructive Pulmonary Disease
- Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects — Hershey, Pennsylvania
- A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD — Chandler, Arizona
- Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD — Miami, Florida
- A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD — Bakersfield, California
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Birmingham, Alabama
- Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease — Birmingham, Alabama
Explore by condition: All Chronic Obstructive Pulmonary Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.